Compile Data Set for Download or QSAR
maximum 50k data
Found 234 Enz. Inhib. hit(s) with Target = 'Cathepsin L2'
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM19778((2S)-2-(1-benzofuran-2-ylformamido)-4-methyl-N-[(4...)
Affinity DataKi:  0.0630nMAssay Description:Potential inhibitors were evaluated using the progress curve method. Assays were carried out in the presence of variable concentrations of test compo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM19769((2S)-2-(1-benzofuran-2-ylformamido)-4-methyl-N-[(4...)
Affinity DataKi:  1.80nMAssay Description:Potential inhibitors were evaluated using the progress curve method. Assays were carried out in the presence of variable concentrations of test compo...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103351(US8552202, Compound 3)
Affinity DataKi:  100nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103364(US8552202, Compound 13)
Affinity DataKi:  170nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336482(CHEMBL1668599 | citibrasine)
Affinity DataKi:  200nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103358(US8552202, Compound 9)
Affinity DataKi:  240nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50385972(CHEMBL2042470)
Affinity DataKi:  400nMAssay Description:Competitive inhibition of human recombinant cathepsin V expressed in Pichia pastoris using Z-Phe-Arg-MCA as substrate by Lineweaver-Burk plot analysi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336477(1,3,5-trihydroxy-4-methoxy-10-methyl-2,8-bis(3-met...)
Affinity DataKi:  500nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103350(US8552202, Compound 2)
Affinity DataKi:  700nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50385977(CHEMBL2042446)
Affinity DataKi:  800nMAssay Description:Noncompetitive inhibition of human recombinant cathepsin V expressed in Pichia pastoris using Z-Phe-Arg-MCA as substrate by Lineweaver-Burk plot anal...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50385984(CHEMBL2042454)
Affinity DataKi:  800nMAssay Description:Uncompetitive inhibition of human recombinant cathepsin V expressed in Pichia pastoris using Z-Phe-Arg-MCA as substrate by Lineweaver-Burk plot analy...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336481(CHEMBL451705 | citrusinine I | citrusinine-I)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50385962(CHEMBL2042461)
Affinity DataKi:  1.10E+3nMAssay Description:Uncompetitive inhibition of human recombinant cathepsin V expressed in Pichia pastoris using Z-Phe-Arg-MCA as substrate by Lineweaver-Burk plot analy...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336478(1,3,5-trihydroxy-4-methoxy-2-(3-methylbut-2-enyl)-...)
Affinity DataKi:  1.10E+3nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336476(1,3,5-trihydroxy-2,8-bis(3-methylbut-2-enyl)-10-me...)
Affinity DataKi:  1.20E+3nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50385966(CHEMBL2042465)
Affinity DataKi:  1.30E+3nMAssay Description:Competitive inhibition of human recombinant cathepsin V expressed in Pichia pastoris using Z-Phe-Arg-MCA as substrate by Lineweaver-Burk plot analysi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336486(3,4-dihydro-3,5,8-trihydroxy-6-methoxy-2,2,7-trime...)
Affinity DataKi:  1.70E+3nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103363(US8552202, Example 3)
Affinity DataKi:  1.70E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103365(US8552202, Compound 14)
Affinity DataKi:  1.80E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103349(US8552202, Compound 1)
Affinity DataKi:  1.90E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103357(US8552202, Compound 8)
Affinity DataKi:  2.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  3.20E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336480(1,3,5-trihydroxy-4-methoxy-10-methylacridone | CHE...)
Affinity DataKi:  4.20E+3nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336485(2,3-dihydro-4,9-dihydroxy-2-(2-hydroxy-propan-2-yl...)
Affinity DataKi:  4.40E+3nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103356(US8552202, Compound 7)
Affinity DataKi:  5.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103348(US8552202, 63)
Affinity DataKi:  5.70E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM34544(US8552202, Compound 38)
Affinity DataKi:  5.70E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103354(US8552202, Example 1)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50336479(CHEMBL1668598 | glycocitrine-I)
Affinity DataKi:  1.00E+4nMAssay Description:Inhibition of human recombinant cathepsin V expressed in Pichia pastoris by Lineweaver-Burk double-reciprocal plotsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103355(US8552202, Compound 6)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103366(US8552202, Compound 15)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103359(US8552202, Compound 10)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103360(US8552202, Compound 11)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103361(US8552202, Example 2)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103362(US8552202, Compound 12)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM103352(US8552202, Compound 4)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414641(CHEMBL554065)
Affinity DataIC50:  2nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414640(CHEMBL562844)
Affinity DataIC50:  3.16nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414638(CHEMBL549378)
Affinity DataIC50:  6.31nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414639(CHEMBL550872)
Affinity DataIC50:  6.31nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414642(CHEMBL549791)
Affinity DataIC50:  7.94nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50331557(2-chloro-N-(1-(1-methyl-1H-pyrazol-3-ylamino)-1,2-...)
Affinity DataIC50:  16.6nMAssay Description:Inhibition of human cathepsin V by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414637(CHEMBL562915)
Affinity DataIC50:  19.9nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50602542(CHEMBL4594870)
Affinity DataIC50:  20.6nMAssay Description:Inhibition of human recombinant Cathepsin V assessed remaining activity using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50414636(CHEMBL559880)
Affinity DataIC50:  25.1nMAssay Description:Inhibition of cathepsin L2 assessed as inhibition of fluorogenic substrate cleavageMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50331769((S)-N-((S)-1-cyano-2-(4-cyano-2-fluorophenyl)ethyl...)
Affinity DataIC50:  28nMAssay Description:Inhibition of human Cat VMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50165427(CHEMBL194068 | [(S)-1-((R)-1-Phenyl-ethylaminooxal...)
Affinity DataIC50:  29nMAssay Description:Inhibitory concentration against human cathepsin V by fluorescence assay using 2 uM Cbz-Phe-Arg-AMC More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50331555(CHEMBL1289305 | N-(1-(1H-pyrazol-3-ylamino)-1,2-di...)
Affinity DataIC50:  29.5nMAssay Description:Inhibition of human cathepsin V by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCathepsin L2(Homo sapiens (Human))
Gsk

LigandPNGBDBM50331556(2-chloro-N-(4-(1-methyl-1H-pyrazol-3-ylamino)-3,4-...)
Affinity DataIC50:  36.3nMAssay Description:Inhibition of human cathepsin V by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 234 total ) | Next | Last >>
Jump to: